A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome *.
Vincent, Jean-Louis MD, PhD; Artigas, Antonio MD, PhD; Petersen, Lars C. PhD, DSc; Meyer, Christian MD, PhD
[Article] Critical Care Medicine. 37(6):1874-1880, June 2009.

(Format: HTML, PDF)